WHO Immunization Implementation Guide
1.0.0 - release

This page is part of the Immunizations (v1.0.0: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

PlanDefinition: IMMZ.D2.DT.Measles.Ongoing transmission

Official URL: http://smart.who.int/immunizations/PlanDefinition/IMMZD2DTMeaslesOngoingTransmission Version: 1.0.0
Draft as of 2026-10-02 Computable Name: IMMZD2DTMeaslesOngoingTransmission

IMMZ.D2.DT.Measles.Ongoing transmission Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)

Id: IMMZD2DTMeaslesOngoingTransmission
Url: IMMZ.D2.DT.Measles.Ongoing transmission
Version: 1.0.0
Title: IMMZ.D2.DT.Measles.Ongoing transmission
Status: draft
Type:

system: http://terminology.hl7.org/CodeSystem/plan-definition-type

code: eca-rule

Date: 2026-10-02 09:40:20+0000
Publisher: WHO
Description:

IMMZ.D2.DT.Measles.Ongoing transmission Countries with ongoing transmission in which the risk of measles mortality remains high (countries that provide first dose of measles-containing vaccine (MCV) at 9 months and second dose of MCV at 15 months)
Knowledge Capability: computable
Related Artifacts:

References

  • ​

    WHO recommendations for routine immunization - summary tables (January 2025)
Libraries:
IMMZD2DTMeaslesOngoingTransmissionLogic
Actions:
Determine if the client is due for MCV1 in countries with ongoing transmission.: Determine if the client is due for measles vaccination MCV1 according to the national immunization protocol. Countries with ongoing transmission in which the risk of measles mortality remains high.
If: Applicability: Client is due for MCV1 (Client is due for MCV1)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE9', display: 'Measles-containing vaccines' } }, display: 'Measles-containing vaccines' })
Determine if the client is due for MCV2 in countries with ongoing transmission.: Determine if the client is due for measles vaccination MCV2 according to the national immunization protocol. Countries with ongoing transmission in which the risk of measles mortality remains high.
If: Applicability: Client is due for MCV2 (Client is due for MCV2)
Then: Definition: IMMZD2DTMR
Dynamic Values:
status: ('draft')
intent: ('proposal')
medication: (Concept { codes: { Code { system: 'http://smart.who.int/immunizations/CodeSystem/IMMZ.Z', code: 'DE9', display: 'Measles-containing vaccines' } }, display: 'Measles-containing vaccines' })
Check for Guidance for the patient regarding IMMZ.D2.DT.Measles.Ongoing transmission.: Show Guidance for the patient regarding IMMZ.D2.DT.Measles.Ongoing transmission.
If: Applicability: Has Guidance (Has Guidance)
Then: Definition: IMMZ.D2.DT.CR
Dynamic Values:
status: ('active')
payload.contentString: (Guidance)
category.coding: (Code { system: 'http://terminology.hl7.org/CodeSystem/communication-category', code: 'alert' })
priority: (Code { system: 'http://hl7.org/fhir/request-priority', code: 'routine' })